C0022209||isoniazid
C0035608||rifampicin
C0014964||ethambutol
C0034239||pyrazinamide
C0008565||liquid chromatography
C1709895||remediable
C1320680||poor treatment response
C1254351||drug
C0041296||tuberculosis
C0041296||tuberculosis
C0032105||plasma
C0003237||anti-TB drugs
C0872318||LC-MS
C0037813||MS
C0003237||anti-TB drugs
C0032105||plasma
C1720825||therapeutic drug monitoring
C1720825||therapeutic drug monitoring
C0022262||isotopically labeled compounds
C0444263||Plasma samples
C0022885||extracted
C3815102||protein precipitation
C0001963||methanol
C0050456||acetonitrile
C0013227||drugs
C3469601||mobile phases
C0043047||water
C0001963||methanol
C0051704||ammonium acetate
C0016576||formic acid
C0022209||isoniazid
C0035608||rifampicin
C0014964||ethambutol
C0034239||pyrazinamide
C0013227||drugs
C0872318||LC-MS
C0037813||MS
C0003237||anti-TB drugs
C0032105||plasma
C1720825||therapeutic drug monitoring